UNITED STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
Current
Report
PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934
Date
of Report (Date
of earliest event reported):
January
20, 2009
ULTRALIFE
CORPORATION
(Exact
name of registrant as specified in its charter)
Delaware
(State
or other jurisdiction of incorporation or organization)
0-20852 |
16-1387013 |
(Commission File Number)
|
(I.R.S. Employer Identification No.)
|
2000 Technology Parkway, Newark, New York 14513 |
(Address of principal executive offices) (Zip Code) |
(315)
332-7100
(Registrant’s telephone number, including area
code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
⃞ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
⃞ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
⃞ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
⃞ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 2.02. Results of Operations and Financial Condition.
Ultralife Corporation (the “Company”) announced that, based on a preliminary review of results for the fourth quarter ended December 31, the company expects to report revenue for the fourth quarter of approximately $49 million, an increase of 33% compared with $36.8 million reported in the same three-month period in 2007, bringing revenue to approximately $117 million for the second half of 2008.
The Company’s press release is attached as Exhibit 99.1 to this Form 8-K. The information set forth in this Form 8-K and the attached exhibit is being furnished to and not filed with the Securities and Exchange Commission and shall not be deemed to be incorporated by reference in any filing under the Securities Exchange Act of 1934, as amended, or the Securities Act of 1933, as amended, except to the extent specifically provided in any such filing.
Item 9.01. Financial Statements, Pro Forma Financials and Exhibits.
(a) Exhibits.
99.1 Press Release dated January 20, 2009.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
ULTRALIFE CORPORATION |
||
Dated: |
January 20, 2009 |
By: |
/s/ Robert W. Fishback |
|
Vice President of Finance & CFO |
INDEX TO EXHIBITS
(99) Additional Exhibits
99.1 Press Release dated January 20, 2009.
3